India’s Bharat Biotech Completes Trials Of Nation’s First Rotavirus Vaccine
This article was originally published in PharmAsia News
Executive Summary
India’s Bharat Biotech has completed trials of a rotavirus vaccine that could become the nation’s first indigenous preventative for the disease and only the fourth in the world.